Alpha eye drops Eye drops 0,8 mg / ml Naphazoline Decongestant Bottle 10 ml

WARNINGS
The product, although having poor systemic absorption, should be used with caution in patients suffering from hypertension, hyperthyroidism, cardiac disorders, bronchial asthma and hyperglycemia (diabetes). Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require medical attention. The product should be kept out of reach of children as accidental ingestion can cause CNS depression (marked sedation or hypotonia). Since the product, in the 10 ml bottle, contains benzalkonium chloride, soft contact lenses should not be worn during treatment. Since benzalkonium chloride is not present in the single-dose package, this can be used by contact lens wearers, or by those who show hypersensitivity to benzalkonium chloride.
PHARMACOTHERAPEUTIC CATEGORY
Decongestants and antiallergics.
STORAGE
Eye drops (10 ml bottle): store in the original package. Validity after first opening: 30 days. Eye drops (single-dose container): store in the original package. Store at a temperature not exceeding 30 degrees C. Contains no preservatives; for this reason each single-dose container, once opened, must be thrown away after use, even if only partially used.
CONTRAINDICATIONS / SECONDARY EFFECT
It should not be used by people with narrow-angle glaucoma or other serious eye diseases. Hypersensitivity to components or to other strictly correlated substances from a chemical point of view. It should not be used in children under the age of twelve. Simultaneous treatment with monoamine oxidase inhibitors.
NAME
EYE DROPS ALPHA 0,8 MG / ML EYE DROPS, SOLUTION
EXCIPIENTS
Eye drops (10 ml bottle): sodium chloride, monobasic potassium phosphate, disodium phosphate dodecahydrate, benzalkonium chloride, hamamelis virginiana concentrated distilled water, ethyl alcohol, camphor, water for injections. Eye drops (single-dose container): sodium chloride, monobasic potassium phosphate, disodium phosphate dodecahydrate, witch hazel virginiana concentrated distilled water, ethyl alcohol, camphor, water for injections.
SIDE EFFECTS
The use of the product can sometimes cause pupillary dilation, systemic absorption effects (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. Hypersensitivity phenomena may rarely occur. In this case it is necessary to interrupt the treatment and consult the doctor so that, if necessary, suitable therapy can be instituted. The patient is invited to report to the attending physician or pharmacist the possible appearance of undesirable effects not described.
PREGNANCY AND BREASTFEEDING
During pregnancy and lactation use only in case of actual necessity, under direct medical supervision.
INDICATIONS
Redness, tearing, burning and itching of the eyes caused by irritative phenomena (excessive exposure to dust, smoke, etc.).
INTERACTIONS
It should not be used in subjects undergoing treatment with antidepressant drugs (MAOIs) and in the two weeks following such treatment as serious hypertensive crises may arise.
DOSAGE
Eye drops: 1-2 drops in the conjunctival sac once or twice a day. Strictly adhere to the recommended doses. In case of persistent aggravation of symptoms after a short treatment period, consult your doctor. In any case, the product should not be used for more than 4 consecutive days, unless otherwise prescribed, as undesirable effects may occur. A higher dosage of the product even if taken topically and for a short period of time can 'give rise to serious systemic effects.
ACTIVE PRINCIPLES
1 ml of solution contains 0.8 mg naphazoline nitrate.